About Us

“Embracing the technology of today to create the solutions of tomorrow”

The origins of Phoenix  stem from founder and Managing Director Stuart McCully’s previous company, CHCUK. The aim of CHCUK was to provide regulatory compliance solutions for Non-Interventional Studies (NIS) and Real World Evidence (RWE) studies. Sold to a top 5 CRO in 2016, Stuart took all that he had learned from CHCUK and put it into Phoenix, embracing the technology of today to create the solutions of tomorrow.

Phoenix has been designed from the start to carry on the good work of CHCUK, offering a way of producing healthcare research that is easier than ever before.

Since 2016, there has been incredible demand for real world research studies (i.e., clinical studies that are not clinical trials). This growth has only been bolstered by the COVID-19 pandemic, with more government regulators asking for high quality data gained through observational studies. These studies are precisely what the team at Phoenix supports.

Real World Research Regulations

In July 2020, Stuart teamed up with Ken Ashman and Mark Lorkowski to create another real world research offering, through a start-up called Real World Research Limited (less formally known as ‘RedBird’).  The use of deeptech allows the team to provide simple and elegant tools to support the conduct of, and provide confidence in, real world evidence generating studies. Alongside this, the team also keep up with how developments in real world research can impact how studies are run or address regulator expectations. The RedBird team have called this proprietary tool “HawkEye”, as it offers real-time updates and insights.

Find out more about Real World Research Limited (less formally known as ‘RedBird’) at: